Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:47:29.561Z.
Calculation as of: 2026-10-06T18:47:29.561Z.
Quote observation: 2026-10-06T18:45:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7a3ccde1bd0df5c55ebc0148063105fff0bf751cb52a3071af3e3331f6001fbe
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Oculis Holding AG
Market Cap
$494.32M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$500.26M
Operating Cash Flow Yield
6.11%
TTM Avg
7.17%
3Y Avg
9.90%
5Y Avg
6.64%
Market Cap
$488.38M
Operating Cash Flow Yield
8.43%
TTM Avg
13.05%
3Y Avg
17.35%
5Y Avg
16.73%
Market Cap
$509.10M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$510.17M
Operating Cash Flow Yield
0.27%
TTM Avg
0.34%
3Y Avg
0.34%
5Y Avg
0.34%
Market Cap
$472.88M
Operating Cash Flow Yield
N/A
TTM Avg
0.90%
3Y Avg
0.90%
5Y Avg
0.90%
Market Cap
$513.70M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.20M
Operating Cash Flow Yield
N/A
TTM Avg
18.97%
3Y Avg
18.89%
5Y Avg
14.32%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $494.32M | N/A | N/A | N/A | N/A |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.26M | 6.11% | 7.17% | 9.90% | 6.64% |
| Puma Biotechnology, Inc. (PBYI)vs › | $488.38M | 8.43% | 13.05% | 17.35% | 16.73% |
| Evolus, Inc. (EOLS)vs › | $487.52M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $509.10M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $510.17M | 0.27% | 0.34% | 0.34% | 0.34% |
| Alpha Teknova, Inc. (TKNO)vs › | $472.88M | N/A | 0.90% | 0.90% | 0.90% |
| Crescent Biopharma, Inc. (CBIO)vs › | $513.70M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $475.20M | N/A | 18.97% | 18.89% | 14.32% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.89M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
